Neurophet Showcases 'Brain Imaging AI Solutions' at BIO USA, Accelerates Global Business Development Collaborations

• Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-making
• Expands partnering efforts with global pharmaceutical and biotech companies as well as potential customers, while introducing its ICL services

SEOUL, South Korea, June 16, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it will participate in the 2026 BIO International Convention (BIO USA), which will be held in San Diego, the United States, from June 22 to 25.

At this year's BIO USA, Neurophet will showcase Neurophet AQUA AD Plus, an integrated brain imaging analysis solution designed to support treatment decision-making for Alzheimer's disease therapies. Neurophet AQUA AD Plus quantitatively analyzes magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to support imaging-based clinical decision-making across the entire treatment journey — from assessing patient eligibility prior to treatment administration, to monitoring treatment-related side effects during therapy, and evaluating therapeutic outcomes after treatment.

Neurophet will operate a booth at the Korea Pavilion jointly organized by the Korea Biotechnology Industry Organization and the Korea Trade-Investment Promotion Agency (KOTRA), where it will showcase Neurophet AQUA AD Plus, along with Neurophet AQUA, a neurodegenerative brain imaging analysis software, and Neurophet SCALE PET, a PET image quantification software.

Through its participation in BIO USA, Neurophet plans to engage in partnering with global pharmaceutical and biotechnology companies as well as potential customers to explore business development collaborations in the imaging contract research organization (CRO) sector. In particular, the company will introduce its imaging core lab (ICL) services for analyzing neuroimaging biomarkers, which are widely used as key indicators in clinical trials for the development of Alzheimer's disease and Parkinson's disease therapies.

"Global demand for Neurophet AQUA AD PLUS is steadily rising among leading medical institutions in the field of imaging analysis for Alzheimer's disease treatments," said Jake Junkil Been, Co-CEO of Neurophet. "Our participation in BIO USA will serve as a catalyst to accelerate business development collaborations in the ICL sector and expand strategic partnerships with major global pharmaceutical companies."

Meanwhile, BIO USA is the world's largest pharmaceutical and biotechnology exhibition, serving as a premier networking platform where industry professionals gather to share the latest biotech advancements and industry trends.

About Neurophet

Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.

Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".

Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Neurophet Showcases 'Brain Imaging AI Solutions' at BIO USA, Accelerates Global Business Development Collaborations

LOS ANGELES, June 17, 2026 /PRNewswire/ -- As millions of shoppers prepare for Prime Day deals, Bedlore is inviting customers to do more than save money—it's encouraging them to transform their sleep experience with its best-selling Bamboo Mattress Topper while participating in an exciting giveaway featuring an iPhone 17, the latest iPad, and other prizes.

With summer temperatures rising, Bedlore's Bamboo Mattress Topper offers an affordable way to add comfort, breathability, and cooling support without the expense of replacing an existing mattress.

Crafted with a premium bamboo-blend surface containing 40% bamboo fibers, the topper is designed to promote airflow and reduce heat retention throughout the night. Its cooling properties make it particularly appealing for hot sleepers, individuals living in warmer climates, and anyone looking to improve sleep comfort during the summer months.

In addition to temperature regulation, the bamboo fabric offers an exceptionally soft, skin-friendly sleeping surface. The gentle texture helps create a more comfortable sleep environment, making it suitable for individuals who value both comfort and breathability.

Bedlore's carefully engineered quilted construction further enhances the sleeping experience. The design helps maintain even distribution of the filling, reducing common issues such as shifting, clumping, and sagging over time. The result is consistent comfort and support night after night.

Available in Twin, Twin XL, Full, Queen, King, and California King sizes, the Bamboo Mattress Topper accommodates a wide variety of needs, from college dorm rooms and guest bedrooms to master suites.

To make ownership even easier, the topper is fully machine washable, allowing users to keep it fresh and clean with minimal effort.

Prime Day Savings and Exclusive Giveaway

During the Prime Day promotion, customers can enjoy limited-time discounts across Bedlore's mattress topper collection through the official Bedlore store.

In addition to special pricing, Bedlore is launching a series of interactive giveaway events throughout the campaign. Participants will have opportunities to win:

• iPhone 17
• Latest-generation iPad
• Free Bedlore Mattress Toppers
• Exclusive discount coupons
• Additional surprise rewards announced during the event

The giveaway campaign is designed to reward both new and existing customers while encouraging participation throughout the campaign.

As details of the surprise promotions are gradually revealed, shoppers are encouraged to follow Bedlore's social channels and community platforms to stay informed about new opportunities to participate and win.

Upgrade Your Sleep This Prime Day

Whether you're looking to sleep cooler, refresh an aging mattress, or simply create a more comfortable sleep environment, Bedlore's Bamboo Mattress Topper offers an affordable way to upgrade your nightly rest.

This Prime Day, shoppers can enjoy exceptional savings, premium comfort, and the chance to take home a range of prizes offered throughout the promotion—all while investing in better sleep.

Bedlore

Bedlore is a sleep-focused home essentials brand dedicated to helping people create a more comfortable, restful, and rejuvenating sleep environment. From innovative mattress toppers and mattress protectors to premium bedding solutions, Bedlore combines thoughtful design, quality materials, and practical functionality to enhance everyday sleep experiences.

To find more mattress pad on Bedlore, visit the Bedlore Amazon Store. For more information, visit Bedlore's official website https://www.bedlore.com/.

Stay in touch with Bedlore on social media at @bedlorehome.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Bedlore Launches Prime Day Sleep Upgrade Event with Exclusive Discounts and a Chance to Win an iPhone 17